Barrier to distribute cold sore cream in Canada

Denavir (penciclovir cream) 1% is a topical antiviral prescription medication indicated for the treatment of herpes labialis, also known as cold sores, in adults. This is the only topical antiviral prescription product approved by Health Canada for treating this condition.

Under the terms of the agreement, Barrier will be the exclusive distributor of Denavir in Canada and will be responsible for all sales, marketing and distribution activities. Novartis Consumer Health will be responsible for supplying Barrier with finished goods.

“We can now offer physicians in Canada a unique prescription treatment option, not previously marketed in Canada, which is specifically indicated for treating patients who experience the outbreaks of cold sores,” said Joan Chypyha, general manager of Barrier Therapeutics Canada.

A cold sore is a common occurrence caused by a virus known as herpes simplex type 1 (HSV1) which appears on the outside of the mouth, usually on the face or around the lips. Cold sores are highly contagious and can spread from person to person in a variety of ways, including sharing eating utensils or close skin contact. Signs and symptoms of a cold sore include a tingling discomfort or itching that can lead to painful lesions.